Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 29/03/11 |
Sian Bigora
FOU | Founder | 63 | 29/03/11 |
David Young
FOU | Founder | 71 | 29/03/11 |
Patrick Lin
FOU | Founder | 58 | 29/03/11 |
George Ng
CEO | Chief Executive Officer | 49 | 08/08/23 |
Jim Stanker
DFI | Director of Finance/CFO | 67 | 05/09/18 |
Weifei Ye
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kayla Parks
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Mary Nyberg
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 08/08/23 |
James Neal
BRD | Director/Board Member | 68 | 16/07/22 |
Justin Yorke
CHM | Chairman | 58 | 02/10/17 |
Patrick Lin
FOU | Founder | 58 | 29/03/11 |
David Young
FOU | Founder | 71 | 29/03/11 |
Director/Board Member | 66 | 11/07/22 | |
Geraldine Pannu
BRD | Director/Board Member | 54 | 13/02/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 2 863 007 | 2 512 049 ( 87,74 %) | 5 000 ( 0,1746 %) | 87,74 % |
Información de la empresa
Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive Suite 106
21076, Hanover
+
http://www.processapharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+32,09 % | 694 mil M | |
+29,39 % | 593 mil M | |
-1,34 % | 371 mil M | |
+20,34 % | 331 mil M | |
+7,39 % | 290 mil M | |
+14,25 % | 239 mil M | |
-3,03 % | 209 mil M | |
+10,02 % | 209 mil M | |
+8,49 % | 169 mil M |